These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19597050)

  • 1. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER).
    Krahn AD; Healey JS; Chauhan V; Birnie DH; Simpson CS; Champagne J; Gardner M; Sanatani S; Exner DV; Klein GJ; Yee R; Skanes AC; Gula LJ; Gollob MH
    Circulation; 2009 Jul; 120(4):278-85. PubMed ID: 19597050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and clinical assessment of unexplained sudden cardiac arrest in the real-world setting: focus on idiopathic ventricular fibrillation.
    Waldmann V; Bougouin W; Karam N; Dumas F; Sharifzadehgan A; Gandjbakhch E; Algalarrondo V; Narayanan K; Zhao A; Amet D; Jost D; Geri G; Lamhaut L; Beganton F; Ludes B; Bruneval P; Plu I; Hidden-Lucet F; Albuisson J; Lavergne T; Piot O; Alonso C; Leenhardt A; Lellouche N; Extramiana F; Cariou A; Jouven X; Marijon E;
    Eur Heart J; 2018 Jun; 39(21):1981-1987. PubMed ID: 29566157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of exercise stress testing in evaluation of unexplained cardiac arrest survivor.
    Bergeman AT; Robyns T; Amin AS; Wilde AAM; van der Werf C
    Neth Heart J; 2023 Nov; 31(11):444-451. PubMed ID: 37347419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explaining the Unexplained: A Practical Approach to Investigating the Cardiac Arrest Survivor.
    Suna G; Mellor GJ
    Arrhythm Electrophysiol Rev; 2023; 12():e27. PubMed ID: 38124802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ion Channel Diseases as a Cause of Sudden Cardiac Death in Young People: Aspects of Their Diagnosis, Treatment, and Pathogenesis.
    El-Battrawy I; Mügge A; Akin I; Nguyen HP; Milting H; Aweimer A
    Dtsch Arztebl Int; 2024 Oct; (Forthcoming):. PubMed ID: 38961815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Unexplained Cardiac Arrest: Phenotyping and Genetic Testing.
    Alsaeed AH; Alqarawi W
    Card Electrophysiol Clin; 2023 Sep; 15(3):307-318. PubMed ID: 37558301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Genetic Testing for the Cardiomyopathies and Arrhythmias: A Systematic Framework for Establishing Clinical Validity and Addressing Genotypic and Phenotypic Heterogeneity.
    Garcia J; Tahiliani J; Johnson NM; Aguilar S; Beltran D; Daly A; Decker E; Haverfield E; Herrera B; Murillo L; Nykamp K; Topper S
    Front Cardiovasc Med; 2016; 3():20. PubMed ID: 27446933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The yield of a comprehensive investigation protocol for the diagnosis of true idiopathic ventricular fibrillation in a real-life clinical setting.
    Lietava S; Sepsi M; Zidkova J; Synkova I; Kozak M; Krivan L; Vlasinova J; Richter S; Rehor J; Kala P; Bebarova M; Novotny T
    Sci Rep; 2024 Jun; 14(1):14089. PubMed ID: 38890420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors.
    Monda E; Sarubbi B; Russo MG; Caiazza M; Mazzaccara C; Magrelli J; Rubino M; Esposito A; Perna A; Passariello A; Bossone E; Romeo E; Colonna D; Esposito MV; D'Argenio V; Salvatore F; Pacileo G; Crotti L; Frisso G; Limongelli G
    Eur J Prev Cardiol; 2021 Aug; 28(10):1134-1137. PubMed ID: 32715753
    [No Abstract]   [Full Text] [Related]  

  • 10. Out-of-Hospital Cardiac Arrest From Malignant Early Repolarization Syndrome.
    Choi JI; Chan S; Krahn A
    CJC Open; 2024 Jul; 6(7):905-907. PubMed ID: 39026625
    [No Abstract]   [Full Text] [Related]  

  • 11. Correction to "Cardiac Magnetic Resonance Imaging Findings in 2954 COVID-19 Adult Survivors: A Comprehensive Systematic Review".
    J Magn Reson Imaging; 2023 Sep; 58(3):980. PubMed ID: 37368237
    [No Abstract]   [Full Text] [Related]  

  • 12. Naloxone for cardiac arrest: Provocative results and important new questions (invited commentary).
    Lavonas EJ
    Resuscitation; 2024 Sep; 202():110353. PubMed ID: 39116990
    [No Abstract]   [Full Text] [Related]  

  • 13. New exome data question the pathogenicity of genetic variants previously associated with catecholaminergic polymorphic ventricular tachycardia.
    Jabbari J; Jabbari R; Nielsen MW; Holst AG; Nielsen JB; Haunsø S; Tfelt-Hansen J; Svendsen JH; Olesen MS
    Circ Cardiovasc Genet; 2013 Oct; 6(5):481-9. PubMed ID: 24025405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
    Medeiros-Domingo A; Bhuiyan ZA; Tester DJ; Hofman N; Bikker H; van Tintelen JP; Mannens MM; Wilde AA; Ackerman MJ
    J Am Coll Cardiol; 2009 Nov; 54(22):2065-74. PubMed ID: 19926015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
    Kapplinger JD; Tester DJ; Salisbury BA; Carr JL; Harris-Kerr C; Pollevick GD; Wilde AA; Ackerman MJ
    Heart Rhythm; 2009 Sep; 6(9):1297-303. PubMed ID: 19716085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.
    Sy RW; Gollob MH; Klein GJ; Yee R; Skanes AC; Gula LJ; Leong-Sit P; Gow RM; Green MS; Birnie DH; Krahn AD
    Heart Rhythm; 2011 Jun; 8(6):864-71. PubMed ID: 21315846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
    Kapa S; Tester DJ; Salisbury BA; Harris-Kerr C; Pungliya MS; Alders M; Wilde AA; Ackerman MJ
    Circulation; 2009 Nov; 120(18):1752-60. PubMed ID: 19841300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare genetic variants previously associated with congenital forms of long QT syndrome have little or no effect on the QT interval.
    Ghouse J; Have CT; Weeke P; Bille Nielsen J; Ahlberg G; Balslev-Harder M; Appel EV; Skaaby T; Olesen SP; Grarup N; Linneberg A; Pedersen O; Haunsø S; Hastrup Svendsen J; Hansen T; Kanters JK; Salling Olesen M
    Eur Heart J; 2015 Oct; 36(37):2523-9. PubMed ID: 26159999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic basis of long QT and short QT syndromes: a mutation update.
    Hedley PL; Jørgensen P; Schlamowitz S; Wangari R; Moolman-Smook J; Brink PA; Kanters JK; Corfield VA; Christiansen M
    Hum Mutat; 2009 Nov; 30(11):1486-511. PubMed ID: 19862833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
    Kapplinger JD; Tester DJ; Alders M; Benito B; Berthet M; Brugada J; Brugada P; Fressart V; Guerchicoff A; Harris-Kerr C; Kamakura S; Kyndt F; Koopmann TT; Miyamoto Y; Pfeiffer R; Pollevick GD; Probst V; Zumhagen S; Vatta M; Towbin JA; Shimizu W; Schulze-Bahr E; Antzelevitch C; Salisbury BA; Guicheney P; Wilde AA; Brugada R; Schott JJ; Ackerman MJ
    Heart Rhythm; 2010 Jan; 7(1):33-46. PubMed ID: 20129283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.